PAINWEEK–END–EX60[87]-01

AGOURA HILLS, CA

Saturday 4/23/22 | 8:00a-4:40p

This is a 1-day meeting and will provide 6 CE/CME credits.

Register Now!

Pain Management for the Main Street Practitioner

Pain is the primary reason Americans seek healthcare. An aging population and radical expansion in health insurance coverage will converge to keep pain at the forefront of patient presentations. And the rapidly evolving regulatory environment in medication risk management has new and complex implications for patients and practitioners alike.

VENUE

burah-exterior-1791-hor-clsc_O

Sheraton Agoura Hills Hotel
30100 Agoura Rd,
Agoura Hills, CA 91301

Offering Santa Monica Mountain views, this upscale hotel is 7 miles from Sherwood Country Club and 15 miles from Malibu Lagoon State Beach.

Parking and an area shuttle are free. There's also a fusion restaurant and a lounge bar, plus an outdoor heated pool, a fitness center and terrace with a fire pit. 

View hotel website >>

lobby
sheraton-agoura-hills
ab97eea1_z

FACULTY

(Subject to change)

Charles E. Argoff
MD

Michael Bottros
MD

hah-faculty-400x400

Jennifer Hah
MD

Theresa Mallick-Searle
MS, NP-BC, ANP-BC

Ravi Prasad
PhD

MODERATOR

Theresa Mallick-Searle
MS, NP-BC, ANP-BC

Register Now!

COURSE AGENDA

(Faculty and courses subject to change)

8:00a-9:00a — Registration, Breakfast, Coffee, and Exhibits


9:00a-10:00a — Apocalypse Now…or Later? Chronic Pain After COVID-19

Faculty: Michael M. Bottros, MD

As we better understand the acute challenges of managing the COVID-19 pandemic, it is the lingering effects on COVID-19 survivors that healthcare providers are increasingly beginning to treat. Initially viewed as a respiratory disease, it is now clearer that many organ systems are affected due to a systemic inflammatory response. Many COVID-19 survivors have sustained prolonged periods of sedation and immobilization, putting them at increased risk of myopathy and polyneuropathy. Emerging reports of neurological sequelae include nerve pain, confusion, headache, anosmia, and chronic fatigue. This course will shed light on some of these emerging symptoms and potential treatment solutions.

UAN: 0530-0000-22-026-L08-P
Rx hours: 0.20


10:00a-10:15a — Break/Exhibits


10:15a-11:15a — Clinical Update: Utilizing Topical Analgesics for Diabetic Peripheral Neuropathy

Faculty: Charles E. Argoff, MD

Painful diabetic neuropathy is a challenging condition to treat. This course will review the prevalence and impact of painful diabetic neuropathy as well as explore how available topical therapies for this condition can be incorporated into one’s practice. Systemic therapies will also be discussed to provide context for the discussion of topical therapies and because topical therapies are often used in conjunction with systemic treatments.

UAN: 0530-0000-22-008-L01-P
Rx hours: 0.50

Supported by an educational grant from Averitas Pharma, Inc.


11:15a-12:15p — Pink Elephant: Is Alcohol a Pain Panacea or a Problem?

Faculty: Ravi Prasad, PhD & Jennifer M. Hah, MD

Chronic pain and alcohol consumption are both very common in the general population, and alcohol is often used to numb both physical and emotional pain. This relationship is especially salient as estimates of alcohol consumption have increased during the COVID-19 pandemic. In this course, the epidemiology of co-occurring pain and alcohol use will be discussed, and recent figures related to alcohol sales will be reviewed. This session will also provide information on the latest evidence surrounding the interaction between alcohol consumption and pain. For example, moderate alcohol use has been associated with improved pain-related outcomes for certain pain conditions; however, both excessive binge drinking and alcohol use disorder are associated with worsened pain outcomes. The interaction of alcohol with pharmacologic treatments for pain will be reviewed. Furthermore, the presence of pain may serve as a trigger for some to increase alcohol consumption as a maladaptive coping strategy. Behavioral approaches to address this process, to treat co-occurring alcohol use disorder and chronic pain, and to reduce problem drinking will be presented.

UAN: 0530-0000-22-029-L08-P
Rx hours: 0.10


12:15p-12:30p — Break/Exhibits


12:30p-1:30p — Building Confidence and Establishing Best Practices for Administering QUTENZA® (capsaicin) 8% topical system*

Faculty: Stephanie Simon, APRN

This hands-on workshop will allow you to practice the application steps and technique surrounding a QUTENZA treatment. Demonstration topical systems and patient actors will be available for you to gain hands-on experience and develop best practices.

Sponsored by Averitas Pharma, Inc.

Lunch will be served.

*Not certified for credit


1:30p-2:30p — Osteoarthritic Joint Pain: Advances in Diagnosis and Treatment

Faculty: Michael M. Bottros, MD

Joint pain is an unfortunate fundamental problem in patient care and pain management. For example, knee pain is so prevalent that, by 2020, more than 1 million patients had undergone knee replacement surgery. However, there are several different medications and treatments that are options before undergoing surgery, which may not be readily apparent. And what if your patient is not a surgical candidate, or if the pain persists even after joint replacement surgery? In this course, we review the relevant clinical exam findings for diagnosis as well as treatment options for cervical/lumbar facet joint pain through peripheral joints such as the shoulder, hip, and knee.

UAN: 0530-0000-22-028-L08-P
Rx hours: 0.00


2:30p-2:40p — Break/Exhibits


2:40p-3:40p — Back to the Basics: The Role of Psychology in Pain

Faculty: Ravi Prasad, PhD

Our nation's opioid epidemic has caused many patients, clinicians, and payers to seek nonpharmacologic options to assist with managing pain. Psychology has a well-established role in the treatment of pain conditions but familiarity with this subject matter varies widely. It important for clinicians treating pain to have an awareness of the role of psychology in the etiology, maintenance, and treatment of pain and to be able to apply this knowledge in the delivery of clinical care. The session will feature an introduction to pain and an explanation of the evolution of the opioid crisis. We will examine factors known to affect pain, including adverse childhood events and psychosocial variables. Although cognitive behavioral therapy (CBT) based interventions are the most frequently studied and applied treatment paradigms, other lesser known approaches also have demonstrated efficacy in pain care. Thus, CBT for pain will be discussed, followed by a brief overview of biofeedback training, mindfulness based stress reduction, acceptance and commitment therapy, and emotional awareness and expression therapy.

UAN: 0530-0000-22-027-L08-P
Rx hours: 0.00


3:40p-4:40p — Ain't No Honky-Tonk: Medical Cannabis for Pain Management

Faculty: Theresa Mallick-Searle, MS, NP-BC, ANP-BC

We have heard about cannabis, we know a little about the differences between THC and CBD, we have a vague grasp of the endocannabinoid system. Now, your patient wants to try cannabis. What are the BASICS that you need to know? Is this you: “I am a busy clinician and I have 15 minutes to learn all that I need to know about cannabis.” This updated lecture will provide the busy clinician with the basics that they need to safely discuss medical cannabis, including how it works and which conditions it treats, and provide patients with the essentials to move forward safely without harm.

UAN: 0530-0000-22-025-L08-P
Rx hours: 0.20


REGISTRATION INFORMATION

This is a 1-day meeting and will provide 6 CE/CME credit hours.

Conference Fee: $129

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend sponsored meal programs and the scientific sessions. Nonmedical personnel and guests are welcome at the networking reception, and must be accompanied by a PAINWeekEnd Dallas registrant.

SPONSORED PROGRAMS

To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon time slots.

SPONSORS & EXHIBITORS

Averitas Pharma Inc.

Register Now!

Accreditation

PAINWeekEnd Agoura Hills 2022
This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere—and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeek Premiere Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering a full day of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 6.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

  • Describe the potential negative impact that bias, stigma, and social determinants of health can have in the assessment and treatment of pain

  • Summarize current stakeholder perspectives and oversight trends for opioid prescribing

  • Summarize how different types of opioid risk have varying levels of clinical impact

  • Identify key steps in meaningful risk evaluation of new patients and risk monitoring of established patients

  • Describe the importance of understanding the negotiation of pain and suffering

  • Describe how payers now measure and address patient risk

  • Cite potential drug interactions with cannabis

  • Summarize the general tension between the federal and state law regarding the status of cannabis

Faculty

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Department of Neurology
Albany, NY

Michael M. Bottros, MD
Clinical Operations and Medical Director for Pain Services
Keck School of Medicine of the University of Southern California
Los Angeles, CA

Jennifer Hah, MD, MS
Assistant Professor
Stanford University
Stanford, CA

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC
Adult Nurse Practitioner
Stanford Health Care, Division Pain Medicine
San Carlos, CA

Ravi Prasad, PhD
Clinical Professor
University of California, Davis School of Medicine
Sacramento, CA

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 6.0 contact hour(s) (which includes 1.0 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 6.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 6.0 contact hours (0.60 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity. UANs are in the agenda.

Instructions to Receive Credit

Please look for an email from outcomes@globaleducationgroup.com that will be sent to you following this Premiere Webinar. The email will have your personalized link to complete the online conference evaluation form needed to receive your CE/CME certificate. Upon completion of this form, you will be able to download, print, and save your certificate immediately! Please make sure to check your junk mail folder, as this email may be tagged as spam.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The planners and managers reported the following financial relationships or relationships to products or devices they have with ineligible company related to the content of this CME activity:

Rhys Williams, MSN, FNP-C, RN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Andrea Funk—Nothing to disclose
Liddy Knight—Nothing to disclose
Ashley Cann—Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.